Guidant Defibrillator Deal Expanded To $240M

Law360, New York (November 19, 2007, 12:00 AM EST) -- Boston Scientific Corp. upped its settlement in the product liability multidistrict litigation over faulty Guidant Corp. defibrillators on Monday, agreeing to pay $240 million to settle claims from more than 8,500 plaintiffs.

After additional patients stepped forward claiming they had been injured from the implantable heart defibrillators, the medical device maker and the plaintiffs expanded their July deal. That deal would have had Boston Scientific paying $195 million to settle over 5,600 MDL and state court claims.

“This amended agreement is great news for the patient...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.